Sort
39,280 grants matching “leukemia”
Mechanism of inv(16) mediated leukemogenesis
$402,551Scott Hiebert · Vanderbilt University · R01 · FY2007 · CA
Project 1: Overcoming resistance of B cell leukemia to CD19 CAR T Cells.
$402,534David Porter · University Of Pennsylvania · P01 · FY2018 · CA
Molecular Pathogenesis & Therapy of JAK2 V617F-induced Myeloproliferative Disease
$402,500Richard A. Van Etten · Tufts Medical Center · R01 · FY2011 · HL
Molecular Pathogenesis & Therapy of JAK2 V617F-induced Myeloproliferative Disease
$402,500Richard A. Van Etten · Tufts Medical Center · R01 · FY2009 · HL
Effects of human cytomegalovirus on monocyte survival and differentiation
$402,500Gary Ching Tao Chan · Upstate Medical University · R56 · FY2014 · AI
MLL Function in the Maintenance of the Blood Forming System
$402,500Patricia A Ernst · Dartmouth College · R01 · FY2012 · HL
Role of JAK2V617F in the Pathogenesis of Myeloproliferative Neoplasms
$402,500Golam Mohi · Upstate Medical University · R01 · FY2015 · HL
Role of mTOR in thymic epithelial cells in regulating age-associated thymic involution and function
$402,500Xiaoping Zhong · Duke University · R56 · FY2019 · AG
Molecular Pathogenesis & Therapy of JAK2 V617F-induced Myeloproliferative Disease
$402,500Richard A. Van Etten · Tufts Medical Center · R01 · FY2008 · HL
Molecular Pathogenesis & Therapy of JAK2 V617F-induced Myeloproliferative Disease
$402,500Richard A. Van Etten · Tufts Medical Center · R01 · FY2010 · HL
Cooperation of SF3B1 mutations and ATM deletions in the pathogenesis of chronic lymphocytic leukemia
$402,484Lili Wang · Beckman Research Institute/City Of Hope · R01 · FY2024 · CA
The Biology of Promyelocytic Leukemia in a Mouse Model
$402,462Timothy J Ley · Washington University · R01 · FY2006 · CA
Structure and function in Notch Signaling
$402,402Stephen C. Blacklow · Harvard Medical School · R01 · FY2015 · CA
Mediators Of Arrested Differentiation In Pediatric Rhabdomyosarcoma
$402,394Mark Edward Hatley · St. Jude Children'S Research Hospital · R01 · FY2023 · CA
Mediators Of Arrested Differentiation In Pediatric Rhabdomyosarcoma
$402,394Mark Edward Hatley · St. Jude Children'S Research Hospital · R01 · FY2022 · CA
Structural basis for CBP/p300 transcriptional regulation
$402,386Peter Edwin Wright · Scripps Research Institute, The · R01 · FY2006 · CA
The impact of chromosome 17p lesions on leukemogeneis and therapy response
$402,371Scott W Lowe · Sloan-Kettering Inst Can Research · R01 · FY2017 · CA
The impact of chromosome 17p lesions on leukemogeneis and therapy response
$402,371Scott W Lowe · Sloan-Kettering Inst Can Research · R01 · FY2015 · CA
The impact of chromosome 17p lesions on leukemogeneis and therapy response
$402,371Scott W Lowe · Sloan-Kettering Inst Can Research · R01 · FY2016 · CA
The impact of chromosome 17p lesions on leukemogeneis and therapy response
$402,371Scott W Lowe · Sloan-Kettering Inst Can Research · R01 · FY2018 · CA
SOUTHWEST ONCOLOGY GROUP--SUMMARY
$402,352Loyola University Chicago · U10 · FY2003 · CA
Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML
$402,343Michele S. Redell · Baylor College Of Medicine · R01 · FY2016 · CA
E2A as a Tumor Suppressor
$402,282Cornelis Murre · University Of California, San Diego · R01 · FY2009 · CA
Central tolerance mechanisms in B-cell malignancies
$402,275Markus Mãschen · Yale University · R01 · FY2025 · CA
Central tolerance mechanisms in B-cell malignancies
$402,275Markus Mãschen · Yale University · R01 · FY2023 · CA